Found: 8

Select item for more details and to access through your institution.

  • Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.

    Published in:
    Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 321, doi. 10.1007/s10549-019-05211-1
    By:
    • Sambade, Maria J.;
    • Prince, Grace;
    • Deal, Allison M.;
    • Trembath, Dimitri;
    • McKee, Megan;
    • Garrett, Amy;
    • Keith, Kevin;
    • Ramirez, Juanita;
    • Midkiff, Bentley;
    • Blackwell, Kimberly;
    • Sammons, Sarah;
    • Leone, Jose Pablo;
    • Brufsky, Adam;
    • Morikawa, Aki;
    • Brogi, Edi;
    • Seidman, Andrew;
    • Ewend, Matthew;
    • Carey, Lisa A.;
    • Moschos, Stergios J.;
    • Hamilton, Ronald L.
    Publication type:
    Article

  • LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 637, doi. 10.1007/s10549-018-4852-5
    By:
    • Van Swearingen, Amanda E. D.;
    • Siegel, Marni B.;
    • Deal, Allison M.;
    • Sambade, Maria J.;
    • Hoyle, Alan;
    • Hayes, D. Neil;
    • Jo, Heejoon;
    • Little, Paul;
    • Dees, Elizabeth Claire;
    • Muss, Hyman;
    • Jolly, Trevor;
    • Zagar, Timothy M.;
    • Patel, Nirali;
    • Miller, C. Ryan;
    • Parker, Joel S.;
    • Smith, J. Keith;
    • Fisher, Julie;
    • Shah, Nikita;
    • Nabell, Lisle;
    • Nanda, Rita
    Publication type:
    Article

  • Mechanisms of chromosomal instability in melanoma.

    Published in:
    Environmental & Molecular Mutagenesis, 2014, v. 55, n. 6, p. 457, doi. 10.1002/em.21859
    By:
    • Kaufmann, William K.;
    • Carson, Craig C.;
    • Omolo, Bernard;
    • Filgo, Adam J.;
    • Sambade, Maria J.;
    • Simpson, Dennis A.;
    • Shields, Janiel M.;
    • Ibrahim, Joseph G.;
    • Thomas, Nancy E.
    Publication type:
    Article

  • Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.

    Published in:
    Pigment Cell & Melanoma Research, 2014, v. 27, n. 4, p. 653, doi. 10.1111/pcmr.12238
    By:
    • Jeck, William R.;
    • Parker, Joel;
    • Carson, Craig C.;
    • Shields, Janiel M.;
    • Sambade, Maria J.;
    • Peters, Eldon C.;
    • Burd, Christin E.;
    • Thomas, Nancy E.;
    • Chiang, Derek Y.;
    • Liu, Wenjin;
    • Eberhard, David A.;
    • Ollila, David;
    • Grilley ‐ Olson, Juneko;
    • Moschos, Stergios;
    • Neil Hayes, D.;
    • Sharpless, Norman E.
    Publication type:
    Article

  • A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.

    Published in:
    Pigment Cell & Melanoma Research, 2012, v. 25, n. 4, p. 514, doi. 10.1111/j.1755-148X.2012.01010.x
    By:
    • Carson, Craig;
    • Omolo, Bernard;
    • Chu, Haitao;
    • Zhou, Yingchun;
    • Sambade, Maria J.;
    • Peters, Eldon C.;
    • Tompkins, Patrick;
    • Simpson, Dennis A.;
    • Thomas, Nancy E.;
    • Fan, Cheng;
    • Sarasin, Alain;
    • Dessen, Philippe;
    • Shields, Janiel M.;
    • Ibrahim, Joseph G.;
    • Kaufmann, William K.
    Publication type:
    Article

  • MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 5, p. 2257, doi. 10.1172/JCI67816
    By:
    • Schlegel, Jennifer;
    • Sambade, Maria J.;
    • Sather, Susan;
    • Moschos, Stergios J.;
    • Aik-Choon Tan;
    • Winges, Amanda;
    • DeRyckere, Deborah;
    • Carson, Craig C.;
    • Trembath, Dimitri G.;
    • Tentler, John J.;
    • Eckhardt, S. Gail;
    • Pei-Fen Kuan;
    • Hamilton, Ronald L.;
    • Duncan, Lyn M.;
    • Miller, C. Ryan;
    • Nikolaishvili-Feinberg, Nana;
    • Midkiff, Bentley R.;
    • Jing Liu;
    • Weihe Zhang;
    • Chao Yang
    Publication type:
    Article

  • Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.818693
    By:
    • Routh, Eric D.;
    • Van Swearingen, Amanda E. D.;
    • Sambade, Maria J.;
    • Vensko, Steven;
    • McClure, Marni B.;
    • Woodcock, Mark G.;
    • Shengjie Chai;
    • Cuaboy, Luz A.;
    • Wheless, Amy;
    • Garrett, Amy;
    • Carey, Lisa A.;
    • Hoyle, Alan P.;
    • Parker, Joel S.;
    • Vincent, Benjamin G.;
    • Anders, Carey K.
    Publication type:
    Article

  • Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 11, p. 1481, doi. 10.1093/neuonc/nox052
    By:
    • Van Swearingen, Amanda E. D.;
    • Sambade, Maria J.;
    • Siegel, Marni B.;
    • Sud, Shivani;
    • McNeill, Robert S.;
    • Bevill, Samantha M.;
    • Xin Chen;
    • Bash, Ryan E.;
    • Mounsey, Louisa;
    • Golitz, Brian T.;
    • Santos, Charlene;
    • Deal, Allison;
    • Parker, Joel S.;
    • Rashid, Naim;
    • Miller, C. Ryan;
    • Johnson, Gary L.;
    • Anders, Carey K.
    Publication type:
    Article